FIG. 4.

Vortex HE provides improved capture performance for cancer patient samples. (a) Three blood samples each from lung, prostate, and breast cancer patients were collected and processed to compare the performance of Vortex Chip and HE1 devices. The HE1 device is able to collect more CTCs than Vortex Chip. Age-matched samples from two male and one female donors were used to set baseline thresholds. (b) Example of CTCs found from lung, breast, and prostate cancer patients (rows 1, 2, and 3, respectively). The 4th row shows a lung CTC expressing EMT markers. The 5th row shows an example of a rare large CD45+ cell that was collected and counted as WBC.